407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study Article Swipe

PDF

JC Radosa , Thomas Fietz , J. Wilke , Thomas Decker , Volker Petersen , M. Deryal , Juergen A. Knoblich , Christoph Losem , Uwe Rhein , Björn Schöttker , Denise Wrobel , Georg Pfeiler , Emanuele Zanucco , Johanna Buncke , S.M. Woerner , Katja Gratzke , A. Adams , E. Glastetter , Rupert Bartsch , Michael P. Lux ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1016/j.annonc.2023.09.584

Related Topics

Concepts

Medicine Tolerability Palbociclib Internal medicine Breast cancer Interim analysis Population Clinical trial Metastatic breast cancer Oncology Cancer Interim Gynecology Adverse effect History Environmental health Archaeology

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.annonc.2023.09.584
PDF: http://www.annalsofoncology.org/article/S0923753423014205/pdf
OA Status: bronze
Cited By: 3
Related Works: 10
OpenAlex ID: https://openalex.org/W4387826002

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4387826002

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.annonc.2023.09.584

Digital Object Identifier
Title: 407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-10-01

Full publication date if available
Authors: JC Radosa, Thomas Fietz, J. Wilke, Thomas Decker, Volker Petersen, M. Deryal, Juergen A. Knoblich, Christoph Losem, Uwe Rhein, Björn Schöttker, Denise Wrobel, Georg Pfeiler, Emanuele Zanucco, Johanna Buncke, S.M. Woerner, Katja Gratzke, A. Adams, E. Glastetter, Rupert Bartsch, Michael P. Lux

List of authors in order
Landing page: https://doi.org/10.1016/j.annonc.2023.09.584

Publisher landing page
PDF URL: https://www.annalsofoncology.org/article/S0923753423014205/pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://www.annalsofoncology.org/article/S0923753423014205/pdf

Direct OA link when available
Concepts: Medicine, Tolerability, Palbociclib, Internal medicine, Breast cancer, Interim analysis, Population, Clinical trial, Metastatic breast cancer, Oncology, Cancer, Interim, Gynecology, Adverse effect, History, Environmental health, Archaeology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 3

Total citation count in OpenAlex
Citations by year (recent): 2025: 2, 2024: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4387826002
doi	https://doi.org/10.1016/j.annonc.2023.09.584
ids.doi	https://doi.org/10.1016/j.annonc.2023.09.584
ids.openalex	https://openalex.org/W4387826002
fwci	1.01212496
type	article
title	407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study
biblio.issue
biblio.volume	34
biblio.last_page	S354
biblio.first_page	S353
topics[0].id	https://openalex.org/T12829
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9998000264167786
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Advanced Breast Cancer Therapies
topics[1].id	https://openalex.org/T10183
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9264000058174133
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1306
topics[1].subfield.display_name	Cancer Research
topics[1].display_name	Breast Cancer Treatment Studies
topics[2].id	https://openalex.org/T10755
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9153000116348267
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	HER2/EGFR in Cancer Research
is_xpac	False
apc_list.value	4060
apc_list.currency	USD
apc_list.value_usd	4060
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9361629486083984
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2778375690
concepts[1].level	3
concepts[1].score	0.8441119194030762
concepts[1].wikidata	https://www.wikidata.org/wiki/Q7814214
concepts[1].display_name	Tolerability
concepts[2].id	https://openalex.org/C2779744173
concepts[2].level	5
concepts[2].score	0.780066192150116
concepts[2].wikidata	https://www.wikidata.org/wiki/Q15269707
concepts[2].display_name	Palbociclib
concepts[3].id	https://openalex.org/C126322002
concepts[3].level	1
concepts[3].score	0.6338548064231873
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[3].display_name	Internal medicine
concepts[4].id	https://openalex.org/C530470458
concepts[4].level	3
concepts[4].score	0.5401685237884521
concepts[4].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[4].display_name	Breast cancer
concepts[5].id	https://openalex.org/C61943457
concepts[5].level	3
concepts[5].score	0.529562771320343
concepts[5].wikidata	https://www.wikidata.org/wiki/Q6046661
concepts[5].display_name	Interim analysis
concepts[6].id	https://openalex.org/C2908647359
concepts[6].level	2
concepts[6].score	0.5080444812774658
concepts[6].wikidata	https://www.wikidata.org/wiki/Q2625603
concepts[6].display_name	Population
concepts[7].id	https://openalex.org/C535046627
concepts[7].level	2
concepts[7].score	0.5059534907341003
concepts[7].wikidata	https://www.wikidata.org/wiki/Q30612
concepts[7].display_name	Clinical trial
concepts[8].id	https://openalex.org/C2775930923
concepts[8].level	4
concepts[8].score	0.504142165184021
concepts[8].wikidata	https://www.wikidata.org/wiki/Q12859063
concepts[8].display_name	Metastatic breast cancer
concepts[9].id	https://openalex.org/C143998085
concepts[9].level	1
concepts[9].score	0.48395422101020813
concepts[9].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[9].display_name	Oncology
concepts[10].id	https://openalex.org/C121608353
concepts[10].level	2
concepts[10].score	0.4333837330341339
concepts[10].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[10].display_name	Cancer
concepts[11].id	https://openalex.org/C2776957806
concepts[11].level	2
concepts[11].score	0.42109331488609314
concepts[11].wikidata	https://www.wikidata.org/wiki/Q4895105
concepts[11].display_name	Interim
concepts[12].id	https://openalex.org/C29456083
concepts[12].level	1
concepts[12].score	0.3351374864578247
concepts[12].wikidata	https://www.wikidata.org/wiki/Q1221899
concepts[12].display_name	Gynecology
concepts[13].id	https://openalex.org/C197934379
concepts[13].level	2
concepts[13].score	0.30718302726745605
concepts[13].wikidata	https://www.wikidata.org/wiki/Q2047938
concepts[13].display_name	Adverse effect
concepts[14].id	https://openalex.org/C95457728
concepts[14].level	0
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q309
concepts[14].display_name	History
concepts[15].id	https://openalex.org/C99454951
concepts[15].level	1
concepts[15].score	0.0
concepts[15].wikidata	https://www.wikidata.org/wiki/Q932068
concepts[15].display_name	Environmental health
concepts[16].id	https://openalex.org/C166957645
concepts[16].level	1
concepts[16].score	0.0
concepts[16].wikidata	https://www.wikidata.org/wiki/Q23498
concepts[16].display_name	Archaeology
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9361629486083984
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/tolerability
keywords[1].score	0.8441119194030762
keywords[1].display_name	Tolerability
keywords[2].id	https://openalex.org/keywords/palbociclib
keywords[2].score	0.780066192150116
keywords[2].display_name	Palbociclib
keywords[3].id	https://openalex.org/keywords/internal-medicine
keywords[3].score	0.6338548064231873
keywords[3].display_name	Internal medicine
keywords[4].id	https://openalex.org/keywords/breast-cancer
keywords[4].score	0.5401685237884521
keywords[4].display_name	Breast cancer
keywords[5].id	https://openalex.org/keywords/interim-analysis
keywords[5].score	0.529562771320343
keywords[5].display_name	Interim analysis
keywords[6].id	https://openalex.org/keywords/population
keywords[6].score	0.5080444812774658
keywords[6].display_name	Population
keywords[7].id	https://openalex.org/keywords/clinical-trial
keywords[7].score	0.5059534907341003
keywords[7].display_name	Clinical trial
keywords[8].id	https://openalex.org/keywords/metastatic-breast-cancer
keywords[8].score	0.504142165184021
keywords[8].display_name	Metastatic breast cancer
keywords[9].id	https://openalex.org/keywords/oncology
keywords[9].score	0.48395422101020813
keywords[9].display_name	Oncology
keywords[10].id	https://openalex.org/keywords/cancer
keywords[10].score	0.4333837330341339
keywords[10].display_name	Cancer
keywords[11].id	https://openalex.org/keywords/interim
keywords[11].score	0.42109331488609314
keywords[11].display_name	Interim
keywords[12].id	https://openalex.org/keywords/gynecology
keywords[12].score	0.3351374864578247
keywords[12].display_name	Gynecology
keywords[13].id	https://openalex.org/keywords/adverse-effect
keywords[13].score	0.30718302726745605
keywords[13].display_name	Adverse effect
language	en
locations[0].id	doi:10.1016/j.annonc.2023.09.584
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S41454044
locations[0].source.issn	0923-7534, 1569-8041
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0923-7534
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of Oncology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license
locations[0].pdf_url	http://www.annalsofoncology.org/article/S0923753423014205/pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of Oncology
locations[0].landing_page_url	https://doi.org/10.1016/j.annonc.2023.09.584
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5016766612
authorships[0].author.orcid
authorships[0].author.display_name	JC Radosa
authorships[0].countries	DE
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210089920
authorships[0].affiliations[0].raw_affiliation_string	Klinik für Frauenheilkunde, UKS - Homburg, University Hospital, Homburg, Germany
authorships[0].institutions[0].id	https://openalex.org/I4210089920
authorships[0].institutions[0].ror	https://ror.org/00a0bqh48
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I2801240073, https://openalex.org/I4210089920
authorships[0].institutions[0].country_code	DE
authorships[0].institutions[0].display_name	Klinik für Frauenheilkunde
authorships[0].author_position	first
authorships[0].raw_author_name	J.C. Radosa
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Klinik für Frauenheilkunde, UKS - Homburg, University Hospital, Homburg, Germany
authorships[1].author.id	https://openalex.org/A5038948892
authorships[1].author.orcid
authorships[1].author.display_name	Thomas Fietz
authorships[1].countries	DE
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210139683
authorships[1].affiliations[0].raw_affiliation_string	Hematology and Oncology Department, Onkologische Schwerpunktpraxis, Singen, Germany
authorships[1].institutions[0].id	https://openalex.org/I4210139683
authorships[1].institutions[0].ror	https://ror.org/03wgek846
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I4210139683
authorships[1].institutions[0].country_code	DE
authorships[1].institutions[0].display_name	Praxis für Hämatologie und Onkologie
authorships[1].author_position	middle
authorships[1].raw_author_name	T. Fietz
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Hematology and Oncology Department, Onkologische Schwerpunktpraxis, Singen, Germany
authorships[2].author.id	https://openalex.org/A5112929115
authorships[2].author.orcid
authorships[2].author.display_name	J. Wilke
authorships[2].countries	DE
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210139683
authorships[2].affiliations[0].raw_affiliation_string	Schwerpunktpraxis Hämatologie & Internistische Onkologie, Fürth, Germany
authorships[2].institutions[0].id	https://openalex.org/I4210139683
authorships[2].institutions[0].ror	https://ror.org/03wgek846
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I4210139683
authorships[2].institutions[0].country_code	DE
authorships[2].institutions[0].display_name	Praxis für Hämatologie und Onkologie
authorships[2].author_position	middle
authorships[2].raw_author_name	J. Wilke
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Schwerpunktpraxis Hämatologie & Internistische Onkologie, Fürth, Germany
authorships[3].author.id	https://openalex.org/A5029656956
authorships[3].author.orcid	https://orcid.org/0000-0003-3814-8775
authorships[3].author.display_name	Thomas Decker
authorships[3].countries	DE
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210097841
authorships[3].affiliations[0].raw_affiliation_string	Onkologie Hamatologie Ravensburg, Ravensburg, Germany
authorships[3].institutions[0].id	https://openalex.org/I4210097841
authorships[3].institutions[0].ror	https://ror.org/014cnmj57
authorships[3].institutions[0].type	education
authorships[3].institutions[0].lineage	https://openalex.org/I4210097841
authorships[3].institutions[0].country_code	DE
authorships[3].institutions[0].display_name	Ravensburg University of Cooperative Education
authorships[3].author_position	middle
authorships[3].raw_author_name	T. Decker
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Onkologie Hamatologie Ravensburg, Ravensburg, Germany
authorships[4].author.id	https://openalex.org/A5113655512
authorships[4].author.orcid
authorships[4].author.display_name	Volker Petersen
authorships[4].countries	DE
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210139683
authorships[4].affiliations[0].raw_affiliation_string	Onkologische Schwerpunktpraxis - Dr Volker Petersen, Heidenheim An Der Brenz, Germany
authorships[4].institutions[0].id	https://openalex.org/I4210139683
authorships[4].institutions[0].ror	https://ror.org/03wgek846
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I4210139683
authorships[4].institutions[0].country_code	DE
authorships[4].institutions[0].display_name	Praxis für Hämatologie und Onkologie
authorships[4].author_position	middle
authorships[4].raw_author_name	V. Petersen
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Onkologische Schwerpunktpraxis - Dr Volker Petersen, Heidenheim An Der Brenz, Germany
authorships[5].author.id	https://openalex.org/A5005485010
authorships[5].author.orcid
authorships[5].author.display_name	M. Deryal
authorships[5].countries	DE
authorships[5].affiliations[0].institution_ids	https://openalex.org/I4210096340
authorships[5].affiliations[0].raw_affiliation_string	Frauenklinik, Caritasklinikum St. Theresia, Saarbruecken, Germany
authorships[5].institutions[0].id	https://openalex.org/I4210096340
authorships[5].institutions[0].ror	https://ror.org/00qkegp41
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I4210096340
authorships[5].institutions[0].country_code	DE
authorships[5].institutions[0].display_name	cts CaritasKlinikum Saarbrücken
authorships[5].author_position	middle
authorships[5].raw_author_name	M. Deryal
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Frauenklinik, Caritasklinikum St. Theresia, Saarbruecken, Germany
authorships[6].author.id	https://openalex.org/A5008803187
authorships[6].author.orcid	https://orcid.org/0000-0002-6751-3404
authorships[6].author.display_name	Juergen A. Knoblich
authorships[6].countries	DE
authorships[6].affiliations[0].institution_ids	https://openalex.org/I2800976808
authorships[6].affiliations[0].raw_affiliation_string	Oncology Department, Onkologie Dreiländereck Dr. Jan Knoblich und Prof. Dr. Richard Fischer, Lörrach, Germany
authorships[6].institutions[0].id	https://openalex.org/I2800976808
authorships[6].institutions[0].ror	https://ror.org/04xpcky34
authorships[6].institutions[0].type	company
authorships[6].institutions[0].lineage	https://openalex.org/I2800976808
authorships[6].institutions[0].country_code	DE
authorships[6].institutions[0].display_name	Fischer (Germany)
authorships[6].author_position	middle
authorships[6].raw_author_name	J. Knoblich
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Oncology Department, Onkologie Dreiländereck Dr. Jan Knoblich und Prof. Dr. Richard Fischer, Lörrach, Germany
authorships[7].author.id	https://openalex.org/A5112976555
authorships[7].author.orcid
authorships[7].author.display_name	Christoph Losem
authorships[7].countries	DE
authorships[7].affiliations[0].institution_ids	https://openalex.org/I4210124504
authorships[7].affiliations[0].raw_affiliation_string	GmbH, TZN - Tumorzentrum Niederrhein, Neuss, Germany
authorships[7].institutions[0].id	https://openalex.org/I4210124504
authorships[7].institutions[0].ror	https://ror.org/02722xq19
authorships[7].institutions[0].type	healthcare
authorships[7].institutions[0].lineage	https://openalex.org/I4210124504
authorships[7].institutions[0].country_code	DE
authorships[7].institutions[0].display_name	Klinik Niederrhein
authorships[7].author_position	middle
authorships[7].raw_author_name	C. Losem
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	GmbH, TZN - Tumorzentrum Niederrhein, Neuss, Germany
authorships[8].author.id	https://openalex.org/A5073437031
authorships[8].author.orcid
authorships[8].author.display_name	Uwe Rhein
authorships[8].affiliations[0].raw_affiliation_string	Frauenheilkunde und Geburtsmedizin, SRH Zentralklinikum Suhl, Suhl, Germany
authorships[8].author_position	middle
authorships[8].raw_author_name	U. Rhein
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Frauenheilkunde und Geburtsmedizin, SRH Zentralklinikum Suhl, Suhl, Germany
authorships[9].author.id	https://openalex.org/A5059057504
authorships[9].author.orcid
authorships[9].author.display_name	Björn Schöttker
authorships[9].countries	DE
authorships[9].affiliations[0].institution_ids	https://openalex.org/I4210139683
authorships[9].affiliations[0].raw_affiliation_string	Hämatologisch-Onkologische Schwerpunktpraxis Wuerzburg, Wuerzburg, Germany
authorships[9].institutions[0].id	https://openalex.org/I4210139683
authorships[9].institutions[0].ror	https://ror.org/03wgek846
authorships[9].institutions[0].type	healthcare
authorships[9].institutions[0].lineage	https://openalex.org/I4210139683
authorships[9].institutions[0].country_code	DE
authorships[9].institutions[0].display_name	Praxis für Hämatologie und Onkologie
authorships[9].author_position	middle
authorships[9].raw_author_name	B. Schöttker
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Hämatologisch-Onkologische Schwerpunktpraxis Wuerzburg, Wuerzburg, Germany
authorships[10].author.id	https://openalex.org/A5006701409
authorships[10].author.orcid
authorships[10].author.display_name	Denise Wrobel
authorships[10].countries	DE
authorships[10].affiliations[0].institution_ids	https://openalex.org/I4210147328
authorships[10].affiliations[0].raw_affiliation_string	Frauenklinik, Klinikum Bamberg, Bamberg, Germany
authorships[10].institutions[0].id	https://openalex.org/I4210147328
authorships[10].institutions[0].ror	https://ror.org/04pa5pz64
authorships[10].institutions[0].type	healthcare
authorships[10].institutions[0].lineage	https://openalex.org/I4210147328
authorships[10].institutions[0].country_code	DE
authorships[10].institutions[0].display_name	Sozialstiftung Bamberg
authorships[10].author_position	middle
authorships[10].raw_author_name	D. Wrobel
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Frauenklinik, Klinikum Bamberg, Bamberg, Germany
authorships[11].author.id	https://openalex.org/A5084303748
authorships[11].author.orcid	https://orcid.org/0000-0002-4763-9165
authorships[11].author.display_name	Georg Pfeiler
authorships[11].affiliations[0].raw_affiliation_string	Deparmtent of Gynecology and Gynecological Oncology, Medizinische Universitaet Wien, Vienna, Austria
authorships[11].author_position	middle
authorships[11].raw_author_name	G. Pfeiler
authorships[11].is_corresponding	False
authorships[11].raw_affiliation_strings	Deparmtent of Gynecology and Gynecological Oncology, Medizinische Universitaet Wien, Vienna, Austria
authorships[12].author.id	https://openalex.org/A5019933637
authorships[12].author.orcid
authorships[12].author.display_name	Emanuele Zanucco
authorships[12].countries	DE
authorships[12].affiliations[0].institution_ids	https://openalex.org/I4210100293
authorships[12].affiliations[0].raw_affiliation_string	Medical Affairs Oncology, Pfizer - Germany, Berlin, Germany
authorships[12].institutions[0].id	https://openalex.org/I4210100293
authorships[12].institutions[0].ror	https://ror.org/00m8w3m39
authorships[12].institutions[0].type	company
authorships[12].institutions[0].lineage	https://openalex.org/I180857899, https://openalex.org/I4210100293
authorships[12].institutions[0].country_code	DE
authorships[12].institutions[0].display_name	Pfizer (Germany)
authorships[12].author_position	middle
authorships[12].raw_author_name	E. Zanucco
authorships[12].is_corresponding	False
authorships[12].raw_affiliation_strings	Medical Affairs Oncology, Pfizer - Germany, Berlin, Germany
authorships[13].author.id	https://openalex.org/A5037107721
authorships[13].author.orcid
authorships[13].author.display_name	Johanna Buncke
authorships[13].countries	DE
authorships[13].affiliations[0].institution_ids	https://openalex.org/I4210100293
authorships[13].affiliations[0].raw_affiliation_string	Health Technology Assessment & Outcomes Research, Pfizer Deutschland GmbH, Berlin, Germany
authorships[13].institutions[0].id	https://openalex.org/I4210100293
authorships[13].institutions[0].ror	https://ror.org/00m8w3m39
authorships[13].institutions[0].type	company
authorships[13].institutions[0].lineage	https://openalex.org/I180857899, https://openalex.org/I4210100293
authorships[13].institutions[0].country_code	DE
authorships[13].institutions[0].display_name	Pfizer (Germany)
authorships[13].author_position	middle
authorships[13].raw_author_name	J. Buncke
authorships[13].is_corresponding	False
authorships[13].raw_affiliation_strings	Health Technology Assessment & Outcomes Research, Pfizer Deutschland GmbH, Berlin, Germany
authorships[14].author.id	https://openalex.org/A5010353950
authorships[14].author.orcid
authorships[14].author.display_name	S.M. Woerner
authorships[14].countries	DE
authorships[14].affiliations[0].institution_ids	https://openalex.org/I4210137496
authorships[14].affiliations[0].raw_affiliation_string	Medical Department, IOMEDICO AG, Freiburg Im Breisgau, Germany
authorships[14].institutions[0].id	https://openalex.org/I4210137496
authorships[14].institutions[0].ror	https://ror.org/03j5af397
authorships[14].institutions[0].type	company
authorships[14].institutions[0].lineage	https://openalex.org/I4210137496
authorships[14].institutions[0].country_code	DE
authorships[14].institutions[0].display_name	Iomedico (Germany)
authorships[14].author_position	middle
authorships[14].raw_author_name	S. Woerner
authorships[14].is_corresponding	False
authorships[14].raw_affiliation_strings	Medical Department, IOMEDICO AG, Freiburg Im Breisgau, Germany
authorships[15].author.id	https://openalex.org/A5024719165
authorships[15].author.orcid
authorships[15].author.display_name	Katja Gratzke
authorships[15].countries	DE
authorships[15].affiliations[0].institution_ids	https://openalex.org/I4210137496
authorships[15].affiliations[0].raw_affiliation_string	Medical Department, IOMEDICO AG, Freiburg Im Breisgau, Germany
authorships[15].institutions[0].id	https://openalex.org/I4210137496
authorships[15].institutions[0].ror	https://ror.org/03j5af397
authorships[15].institutions[0].type	company
authorships[15].institutions[0].lineage	https://openalex.org/I4210137496
authorships[15].institutions[0].country_code	DE
authorships[15].institutions[0].display_name	Iomedico (Germany)
authorships[15].author_position	middle
authorships[15].raw_author_name	K. Gratzke
authorships[15].is_corresponding	False
authorships[15].raw_affiliation_strings	Medical Department, IOMEDICO AG, Freiburg Im Breisgau, Germany
authorships[16].author.id	https://openalex.org/A5046230756
authorships[16].author.orcid
authorships[16].author.display_name	A. Adams
authorships[16].countries	DE
authorships[16].affiliations[0].institution_ids	https://openalex.org/I4210100293
authorships[16].affiliations[0].raw_affiliation_string	Oncology Department, Pfizer - Germany, Berlin, Germany
authorships[16].institutions[0].id	https://openalex.org/I4210100293
authorships[16].institutions[0].ror	https://ror.org/00m8w3m39
authorships[16].institutions[0].type	company
authorships[16].institutions[0].lineage	https://openalex.org/I180857899, https://openalex.org/I4210100293
authorships[16].institutions[0].country_code	DE
authorships[16].institutions[0].display_name	Pfizer (Germany)
authorships[16].author_position	middle
authorships[16].raw_author_name	A. Adams
authorships[16].is_corresponding	False
authorships[16].raw_affiliation_strings	Oncology Department, Pfizer - Germany, Berlin, Germany
authorships[17].author.id	https://openalex.org/A5011618227
authorships[17].author.orcid
authorships[17].author.display_name	E. Glastetter
authorships[17].countries	DE
authorships[17].affiliations[0].institution_ids	https://openalex.org/I4210100293
authorships[17].affiliations[0].raw_affiliation_string	Medical Affairs Oncology, Pfizer - Germany, Berlin, Germany
authorships[17].institutions[0].id	https://openalex.org/I4210100293
authorships[17].institutions[0].ror	https://ror.org/00m8w3m39
authorships[17].institutions[0].type	company
authorships[17].institutions[0].lineage	https://openalex.org/I180857899, https://openalex.org/I4210100293
authorships[17].institutions[0].country_code	DE
authorships[17].institutions[0].display_name	Pfizer (Germany)
authorships[17].author_position	middle
authorships[17].raw_author_name	E. Glastetter
authorships[17].is_corresponding	False
authorships[17].raw_affiliation_strings	Medical Affairs Oncology, Pfizer - Germany, Berlin, Germany
authorships[18].author.id	https://openalex.org/A5041466806
authorships[18].author.orcid	https://orcid.org/0000-0002-4384-6917
authorships[18].author.display_name	Rupert Bartsch
authorships[18].countries	AT
authorships[18].affiliations[0].institution_ids	https://openalex.org/I76134821
authorships[18].affiliations[0].raw_affiliation_string	Department of Medicine 1, Division of Oncology, Medizinische Universitaet Wien, Vienna, Austria
authorships[18].institutions[0].id	https://openalex.org/I76134821
authorships[18].institutions[0].ror	https://ror.org/05n3x4p02
authorships[18].institutions[0].type	education
authorships[18].institutions[0].lineage	https://openalex.org/I76134821
authorships[18].institutions[0].country_code	AT
authorships[18].institutions[0].display_name	Medical University of Vienna
authorships[18].author_position	middle
authorships[18].raw_author_name	R. Bartsch
authorships[18].is_corresponding	False
authorships[18].raw_affiliation_strings	Department of Medicine 1, Division of Oncology, Medizinische Universitaet Wien, Vienna, Austria
authorships[19].author.id	https://openalex.org/A5058627245
authorships[19].author.orcid	https://orcid.org/0000-0002-2781-2178
authorships[19].author.display_name	Michael P. Lux
authorships[19].countries	DE
authorships[19].affiliations[0].institution_ids	https://openalex.org/I4210113917
authorships[19].affiliations[0].raw_affiliation_string	Frauen- und Kinderklinik, St. Vincenz-Krankenhaus GmbH/Frauenklinik, Paderborn, Germany
authorships[19].institutions[0].id	https://openalex.org/I4210113917
authorships[19].institutions[0].ror	https://ror.org/01xet8208
authorships[19].institutions[0].type	healthcare
authorships[19].institutions[0].lineage	https://openalex.org/I4210113917, https://openalex.org/I4210161485
authorships[19].institutions[0].country_code	DE
authorships[19].institutions[0].display_name	Olgahospital
authorships[19].author_position	last
authorships[19].raw_author_name	M.P. Lux
authorships[19].is_corresponding	False
authorships[19].raw_affiliation_strings	Frauen- und Kinderklinik, St. Vincenz-Krankenhaus GmbH/Frauenklinik, Paderborn, Germany
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	http://www.annalsofoncology.org/article/S0923753423014205/pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12829
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9998000264167786
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Advanced Breast Cancer Therapies
related_works	https://openalex.org/W2381648486, https://openalex.org/W2023402573, https://openalex.org/W64094104, https://openalex.org/W2442977450, https://openalex.org/W3140988586, https://openalex.org/W4241346962, https://openalex.org/W4249829394, https://openalex.org/W2746117175, https://openalex.org/W2363503150, https://openalex.org/W3161515104
cited_by_count	3
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	2
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1016/j.annonc.2023.09.584
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S41454044
best_oa_location.source.issn	0923-7534, 1569-8041
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0923-7534
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of Oncology
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.license
best_oa_location.pdf_url	http://www.annalsofoncology.org/article/S0923753423014205/pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of Oncology
best_oa_location.landing_page_url	https://doi.org/10.1016/j.annonc.2023.09.584
primary_location.id	doi:10.1016/j.annonc.2023.09.584
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S41454044
primary_location.source.issn	0923-7534, 1569-8041
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0923-7534
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of Oncology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license
primary_location.pdf_url	http://www.annalsofoncology.org/article/S0923753423014205/pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of Oncology
primary_location.landing_page_url	https://doi.org/10.1016/j.annonc.2023.09.584
publication_date	2023-10-01
publication_year	2023
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year.max	97
cited_by_percentile_year.min	90
countries_distinct_count	2
institutions_distinct_count	20
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5199999809265137
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.78699798
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False